Clinical Trial Update: Fremanezumab Compassionate Use Program for Pediatric Patients

View source ↗

Summary

The update indicates that fremanezumab is available through a compassionate use program for pediatric migraine patients, providing access outside of formal tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Fremanezumab (fremanezumab)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Migraine | Status: AVAILABLE